Riskpilot← Back to searchSign inGet full accessReformkliniken AB
ABActiveOrg 5568903396Själbodgatan 10Medical specialists activities · NACE 8622Est. 201220-49 employees
Revenue 2025
SEK 58,8M
+53% vs 2024
EBITDA margin
18.9%
+79% vs 2024
Equity ratio
41.8%
Financial strength
Net profit 2025
SEK 6,2M
+74% vs 2024
| Revenue | SEK 58,8M | +53% |
| EBITDA | SEK 11,1M | +79% |
| Net profit | SEK 6,2M | +74% |
| Total assets | SEK 23,7M | +51% |
| Equity | SEK 9,9M | +169% |
| Employees | — | — |
Legal name
Reformkliniken AB
Org number
5568903396
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 april 2012
Share capital
SEK 100 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva allmän läkarpraktik, undervisa inom sjukvård, idka operationsverksamhet, idka forskning inom sjukvård, försälja sjukvårdsartiklar, äga och förvalta fast och lös egendom samt idka därmed förenlig verksamhet.
Address
Själbodgatan 10
Email
oxiristm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 29 325 | 30 394 | 28 340 | 38 331 | 58 753 |
| Staff expenses | — | — | — | −14 616 | −16 865 |
| EBITDA | 7 184 | 7 136 | 4 101 | 6 205 | 11 102 |
| Depreciation & amort. | −2 402 | −3 180 | −1 901 | −1 678 | −1 561 |
| EBIT | 4 782 | 3 956 | 2 200 | 4 527 | 9 541 |
| Net financials | — | −18 | 36 | 51 | −6 |
| Profit before tax | 4 560 | 4 858 | 3 707 | 4 578 | 7 868 |
| Tax | −987 | −1 006 | −806 | −999 | −1 655 |
| Net profit | 3 573 | 3 852 | 2 901 | 3 579 | 6 213 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 331 | 18 770 | 14 296 | 15 634 | 23 654 |
| Equity | 6 204 | 5 056 | 3 007 | 3 686 | 9 899 |
| Long-term debt | 427 | 397 | 365 | 332 | 0 |
| Short-term debt | 3 436 | 8 972 | 8 207 | 8 899 | 9 952 |
| Total debt | 3 863 | 9 369 | 8 572 | 9 231 | 9 952 |
EBITDA margin
18.9%
This company
15.8%
Market median
+20% vs market
20212025
Equity ratio
41.8%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
62.8%
This company
18.4%
Market median
+241% vs market
20212025
Net profit margin
10.6%
This company
8.1%
Market median
+31% vs market
20212025
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
20212025
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MT Chief Executive Officer | Chief Executive Officer | 2022 |
KH Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oxiris AB
Reformkliniken AB Board members of Reformkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Tuve Mårten Mårtensson | Chief Executive Officer | 0 companies |
| Karl Henrik Mathias Nilsson | Chief Auditor | 0 companies |
| Antonio Abel Perez | Deputy Board Member | 0 companies |